SIRPant-M: Clinical Trials

1 trial of SIRPant-M, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow SIRPant-M: new trials by email Literature Review of SIRPant-M trials Research Report on SIRPant-M

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
SIRPant-M, External-beam radiotherapy (XRT) - Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma
Phase 1RecruitingSIRPant Immunotherapeutics, Inc.242024-01-172024-12-20

Conditions studied

Lymphoma, Non-Hodgkin (1)

Sponsors

SIRPant Immunotherapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Jelle Kijlstra, MD, MBA (1)